We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Alza Challenges Antitrust Claims In Ditropan Case

Law360 (June 21, 2007, 12:00 AM EDT) -- Alza Corp. has shot back at allegations raised by a purported class of indirect purchasers who claim that the Johnson & Johnson subsidiary violated federal and California antitrust laws by trying to keep generic versions of its bladder treatment Ditropan XL off the U.S. market.

Just days after Alza moved to dismiss the direct purchasers’ antitrust case against it, the Mountain View, Calif.-based company on Thursday contended that the purported class action by indirect purchasers should also be thrown out by the U.S. District Court for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.